MITHRA PHARMACEUTICALS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2160 EUR | -1.82% |
|
-.--% | -82.78% |
| Jun. 11 | Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. acquired Neuralis and Estetra from Mithra Pharmaceuticals SA. | CI |
| May. 28 | Mithra Delays AGM Amid Monetization Process | MT |
Company Valuation: Mithra Pharmaceuticals S.A.
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 752.8 | 989.7 | 841.5 | 880.1 | 186.5 | 14.93 | 14.93 | - |
| Change | - | 31.47% | -14.98% | 4.6% | -78.81% | -91.99% | 0% | - |
| Enterprise Value (EV) 1 | 721 | 1,138 | 1,008 | 1,201 | 486.3 | 396.8 | 14.93 | 14.93 |
| Change | - | 57.88% | -11.45% | 19.14% | -59.5% | -18.42% | -94.09% | 0% |
| P/E ratio | -60.6x | -37.5x | -8.76x | -7.43x | -2.79x | -0.16x | - | - |
| PBR | 4.99x | 6.29x | 5.33x | 25.6x | 5.69x | 0.44x | - | - |
| PEG | - | -0x | -0x | -0.4x | 0.1x | -0x | - | - |
| Capitalization / Revenue | 11.5x | 10.3x | 93.2x | 38.8x | 2.78x | 2.16x | 0.34x | 0.16x |
| EV / Revenue | 11x | 11.8x | 112x | 53x | 7.26x | 9.88x | 0.34x | 0.16x |
| EV / EBITDA | 18.8x | 35.8x | -13.7x | -15.5x | -34x | -7.52x | -0.5x | 0.44x |
| EV / EBIT | 20.3x | 32.5x | -12.6x | -13.7x | -18.5x | -2.85x | - | - |
| EV / FCF | -111x | -19.6x | -11.1x | -14x | -5.9x | -26.9x | - | - |
| FCF Yield | -0.9% | -5.09% | -9% | -7.15% | -17% | -3.72% | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.33 | -0.7 | -2.25 | -2.69 | -1.22 | -1.39 | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 65.46 | 96.5 | 9.03 | 22.67 | 67 | 40.16 | 43.9 | 95.9 |
| EBITDA 1 | 38.31 | 31.82 | -73.81 | -77.45 | -14.3 | -52.77 | -29.6 | 33.6 |
| EBIT 1 | 35.46 | 34.97 | -79.94 | -87.88 | -26.24 | -139.1 | - | - |
| Net income 1 | -12.36 | -26.6 | -92.09 | -116.9 | -59.62 | -173.5 | -55.4 | 13.8 |
| Net Debt 1 | -31.77 | 148.7 | 166.5 | 320.7 | 299.9 | 310.1 | - | - |
| Reference price 2 | 20.0000 | 26.2600 | 19.7000 | 19.9800 | 3.4050 | 0.2160 | 0.2160 | 0.2160 |
| Nbr of stocks (in thousands) | 37,639 | 37,689 | 42,714 | 44,051 | 54,764 | 69,108 | 69,108 | - |
| Announcement Date | 3/1/19 | 3/9/20 | 3/9/21 | 3/8/22 | 3/7/23 | 3/8/24 | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E ratio | EV / Sales | EV / EBITDA | Yield (Y) | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.16x | 6.93x | -4.7x | - | 16.55M | ||
| 31.21x | 6.78x | 19.8x | +1.48% | 97.6B | ||
| 65.97x | 15.67x | 36.14x | -.--% | 53.06B | ||
| 72.42x | 5.64x | 23.64x | +0.87% | 34.28B | ||
| 15.32x | 3.3x | 9.47x | -.--% | 28.5B | ||
| 41.07x | 5.53x | 27.95x | -.--% | 16.16B | ||
| 2366.67x | 225.11x | -3681.63x | - | 12.78B | ||
| 69.12x | 2.32x | 28.57x | -.--% | 12.24B | ||
| 161.63x | 29.11x | 89.97x | +0.10% | 12.12B | ||
| 34x | 5.08x | 14.11x | -.--% | 10.97B | ||
| Average | 285.72x | 30.55x | -343.67x | +0.31% | 27.77B | |
| Weighted average by Cap. | 156.83x | 18.67x | -144.31x | +0.66% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- MITRA Stock
- Valuation Mithra Pharmaceuticals S.A.